Sandra P. Gibson

Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen–Specific T-cell Immunity in Head and Neck Cancer Patients

Steve Lee, Pedro A. Andrade Filho, Christopher A. Lord et al. · Clinical Cancer Research · 2013 · 312 citations · Full text

Life Sciences, Immunology, Oncology +17

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients

Jie Hb, Neil Gildener‐Leapman, Jing Li et al. · British Journal of Cancer · 2013 · 286 citations · Full text

Life Sciences, Immunology, Oncology +17

CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer

Raghvendra M. Srivastava, Sumita Trivedi, Fernando Concha‐Benavente et al. · Clinical Cancer Research · 2016 · 124 citations · Full text

Life Sciences, Immunology, Oncology +17

Human papillomavirus 16 <scp>E</scp>6 antibodies are sensitive for human papillomavirus–driven oropharyngeal cancer and are associated with recurrence

Krystle A. Lang Kuhs, Aimée R. Kreimer, Sumita Trivedi et al. · Cancer · 2017 · 83 citations · Full text

Medicine, Oncology, Cervical Disease +13

Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals

Gulidanna Shayan, Benjamin Kansy, Sandra P. Gibson et al. · Clinical Cancer Research · 2017 · 80 citations · Full text

Medicine, Immunology, Oncology +17